These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Int J Cardiovasc Imaging; 2016 Jan 05; 32(1):49-59. PubMed ID: 25898891 [Abstract] [Full Text] [Related]
5. Identification of inflamed atherosclerotic lesions in vivo using PET-CT. Jezovnik MK, Zidar N, Lezaic L, Gersak B, Poredos P. Inflammation; 2014 Apr 05; 37(2):426-34. PubMed ID: 24282108 [Abstract] [Full Text] [Related]
6. Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study. Strobl FF, Rominger A, Wolpers S, Rist C, Bamberg F, Thierfelder KM, Nikolaou K, Uebleis C, Hacker M, Reiser MF, Saam T. Int J Cardiovasc Imaging; 2013 Dec 05; 29(8):1899-908. PubMed ID: 23979062 [Abstract] [Full Text] [Related]
7. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M, Fuster V, Fayad ZA. Atherosclerosis; 2009 Nov 05; 207(1):139-43. PubMed ID: 19467659 [Abstract] [Full Text] [Related]
8. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging. Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Ikeda H, Yamagishi S, Imaizumi T. JACC Cardiovasc Imaging; 2013 Nov 05; 6(11):1172-82. PubMed ID: 24229770 [Abstract] [Full Text] [Related]
9. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA. JACC Cardiovasc Imaging; 2013 Oct 05; 6(10):1087-1094. PubMed ID: 24135322 [Abstract] [Full Text] [Related]
10. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Kim TN, Kim S, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Circ Cardiovasc Imaging; 2010 Mar 05; 3(2):142-8. PubMed ID: 20061516 [Abstract] [Full Text] [Related]
11. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque. Saito H, Kuroda S, Hirata K, Magota K, Shiga T, Tamaki N, Yoshida D, Terae S, Nakayama N, Houkin K. Cerebrovasc Dis; 2013 Mar 05; 35(4):370-7. PubMed ID: 23635390 [Abstract] [Full Text] [Related]
12. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques. Lei-xing X, Jing-jing G, Jing-xue N, Juan W, Juan L, Chang-zai L, Xiao-xi W, Da-yi Y, Jia-jin L, Xiong-wei Z, Liu-quan C, Yong W, Dan-qing L, Hong-bin L. J Int Med Res; 2014 Feb 05; 42(1):213-23. PubMed ID: 24366494 [Abstract] [Full Text] [Related]
13. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Taqueti VR, Di Carli MF, Jerosch-Herold M, Sukhova GK, Murthy VL, Folco EJ, Kwong RY, Ozaki CK, Belkin M, Nahrendorf M, Weissleder R, Libby P. Circ Cardiovasc Imaging; 2014 Nov 05; 7(6):920-9. PubMed ID: 25170063 [Abstract] [Full Text] [Related]
14. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. deGoma EM, Salavati A, Shinohara RT, Saboury B, Pollan L, Schoen M, Torigian DA, Mohler ER, Dunbar RL, Litt HI, Woo J, Rader DJ, Alavi A, Mehta NN. Acad Radiol; 2015 May 05; 22(5):600-9. PubMed ID: 25708866 [Abstract] [Full Text] [Related]
15. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, Lawler MA, Grinspoon SK, Brady TJ, Nasir K, Hoffmann U, Tawakol A. JACC Cardiovasc Imaging; 2013 Dec 05; 6(12):1250-9. PubMed ID: 24269261 [Abstract] [Full Text] [Related]
16. Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study. Mani V, Woodward M, Samber D, Bucerius J, Tawakol A, Kallend D, Rudd JH, Abt M, Fayad ZA. Int J Cardiovasc Imaging; 2014 Mar 05; 30(3):571-82. PubMed ID: 24458953 [Abstract] [Full Text] [Related]
18. Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging: Implications for Vascular Interventional Studies. van der Valk FM, Verweij SL, Zwinderman KA, Strang AC, Kaiser Y, Marquering HA, Nederveen AJ, Stroes ES, Verberne HJ, Rudd JH. JACC Cardiovasc Imaging; 2016 Oct 05; 9(10):1198-1207. PubMed ID: 27639759 [Abstract] [Full Text] [Related]
19. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). Bucci M, Aparici CM, Hawkins R, Bacharach S, Schrek C, Cheng S, Tong E, Arora S, Parati E, Wintermark M. J Neuroimaging; 2014 Oct 05; 24(2):117-23. PubMed ID: 22928741 [Abstract] [Full Text] [Related]
20. Uptake of F-18 FDG and ultrasound analysis of carotid plaque. Choi YS, Youn HJ, Chung WB, Hwang HJ, Lee DH, Park CS, Lee JB, Kim PJ, Chung WS, Lee MY, Seung KB, Chung YA. J Nucl Cardiol; 2011 Apr 05; 18(2):267-72. PubMed ID: 21279492 [Abstract] [Full Text] [Related] Page: [Next] [New Search]